Nationwide Children hospital pediatric cancer/hematologic cohort; bounded primary-source AMP candidate.
These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.
Release 2026-10-07-1448159e6a81 · Evidence verified: Not verified
Exact outcomes, predictions, identifiers and evaluator are connected.
Missing or unresolved evidence
Verified: Not verified
Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.
Missing or unresolved evidence
Verified: Not verified
A pinned recipe describes the inputs, environment and resource requirements.
Missing or unresolved evidence
Verified: Not verified
Separate data and exposure records support an independent test.
Missing or unresolved evidence
Verified: Not verified
Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.
No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.
2 evaluations · 4 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: Arriba | Protocol: NCH clinically relevant fusion ascertainment Dataset: Nationwide Children hospital pediatric cancer/hematologic cohort | 59 clinically relevant fusions called fusions · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba NCH clinical-ascertainment evaluation name: NCH clinically relevant fusion ascertainment; proposed id: amp-oncology-rna-20261007-protocol-enfusion-nch-clinical; version: 2021 article Table 1 Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 1, Arriba row, Sensitivity column (JATS Tab1) |
| Configuration: Arriba | Protocol: NCH clinically relevant fusion ascertainment Dataset: Nationwide Children hospital pediatric cancer/hematologic cohort | 88.1% sensitivity among ensemble-ascertained clinically relevant fusions % · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba NCH clinical-ascertainment evaluation name: NCH clinically relevant fusion ascertainment; proposed id: amp-oncology-rna-20261007-protocol-enfusion-nch-clinical; version: 2021 article Table 1 Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 1, Arriba row, Sensitivity column (JATS Tab1) |
| Configuration: STAR-Fusion | Protocol: NCH clinically relevant fusion ascertainment Dataset: Nationwide Children hospital pediatric cancer/hematologic cohort | 63 clinically relevant fusions called fusions · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion NCH clinical-ascertainment evaluation name: NCH clinically relevant fusion ascertainment; proposed id: amp-oncology-rna-20261007-protocol-enfusion-nch-clinical; version: 2021 article Table 1 Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 1, STAR-Fusion row, Sensitivity column (JATS Tab1) |
| Configuration: STAR-Fusion | Protocol: NCH clinically relevant fusion ascertainment Dataset: Nationwide Children hospital pediatric cancer/hematologic cohort | 94% sensitivity among ensemble-ascertained clinically relevant fusions % · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceSTAR-Fusion NCH clinical-ascertainment evaluation name: NCH clinically relevant fusion ascertainment; proposed id: amp-oncology-rna-20261007-protocol-enfusion-nch-clinical; version: 2021 article Table 1 Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 1, STAR-Fusion row, Sensitivity (clinically relevant fusions called out of 67) column (JATS Tab1) |
Source checking is not independent reproduction. Release 2026-10-07-1448159e6a81.
A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
7 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.accession Not reported Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | missing or unspecified No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.assay Not reported Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | missing or unspecified No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.population 229 samples: 138 CNS, 73 solid tumors, 18 hematologic malignancies/disorders; 67 clinically relevant fusions in 67 cases Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.split retrospective ascertainment against optimized EnFusion calls Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.version Not reported Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | missing or unspecified No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| description Nationwide Children hospital pediatric cancer/hematologic cohort; bounded primary-source AMP candidate. Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| name Nationwide Children hospital pediatric cancer/hematologic cohort Context-only references | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
View linked audit checks and correction history
Release 2026-10-07-1448159e6a81 · Record review: source checked
Stable ID: amp-oncology-rna-20261007-dataset-enfusion-nch-229